Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus.
El-Serag
Hashem B
HB
Sections of Gastroenterology and Health Services Research, The Houston Center for Quality of Care and Utilization Studies, 2002 Holcombe Boulevard (152), Houston, TX 77030, USA.
Aguirre
Thomas V
TV
Davis
Stephanie
S
Kuebeler
Mark
M
Bhattacharyya
Achyut
A
Sampliner
Richard E
RE
D001471:Barrett Esophagus / Q000150:complications*; D004938:Esophageal Neoplasms / Q000453:epidemiology* / Q000517:prevention & control*; D004947:Esophagus / Q000473:pathology*; D005260:Female; D005500:Follow-Up Studies; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D054328:Proton Pump Inhibitors; D012189:Retrospective Studies
D006635:Histamine H2 Antagonists; D054328:Proton Pump Inhibitors